HemaSeq Dx

HemaSeq Dx - Diagnostická souprava pro hematoonkologii

This is a multidisciplinary, highly innovative project focused on the development of HemaSeq Dx diagnostic kits and panels for the detection of clinically relevant mutations in chronic lymphocytic leukemia and multiple myeloma, including the development of software for the clinical evaluation of mutations. The goal of this industrial development and research is a highly specific and innovative product, targeted at selected groups of patients, while using the next-generation sequencing technique. The project outputs are also based on optical genome mapping technology.

  • Number: CZ.01.1.02/0.0/0.0/16_084/0010310
  • Period: 2017 – 2020
  • Program: Operační program Podnikání a inovace pro konkurenceschopnost (APLIKACE – III. Výzva – s účinnou spoluprací)
  • CZ-NACE: Výzkum a vývoj v oblasti biotechnologie (72.11)
  • Projekt partner: Univerzita Palackého v Olomouci
  • Projekt outputs: Prototyp